Village-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQUET Cohort Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorBeijing Anzhen Hospital

About this trial

This is a prospective observational cohort study conducted in Qujiang District, Zhejiang Province, China, aiming to evaluate the effectiveness of a comprehensive management program for elderly patients with chronic cardiovascular diseases (CVDs). The program integrates pharmacological treatment, lifestyle modification, health education, and long-term follow-up, with enhanced monitoring using 7-day ECG recording. The study focuses on major chronic CVDs including hypertension, coronary artery disease, atrial fibrillation, and heart failure. Approximately 30,000 participants aged ≥60 years will be enrolled and followed for up to 10 years.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Community-dwelling elderly residents of Qujiang District with chronic cardiovascular diseases.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Comprehensive management program (pharmacologic treatment, lifestyle modification, health education, structured follow-up)

    Device

    Comprehensive management program (pharmacologic treatment, lifestyle modification, health education, structured follow-up) Enhanced monitoring with 7-day ECG

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Incidence of cardiovascular events

Incidence of cardiovascular events (myocardial infarction, stroke, hospitalization for heart failure, cardiovascular death) - assessed annually during follow-up

Time frame
10 years
2

All-cause and cardiovascular mortality

All-cause and cardiovascular mortality - assessed at 10 years

Time frame
10 years

Secondary outcomes

1

Hospitalization rates

Hospitalization rates (number and duration of hospitalizations for CVD-related causes)

Time frame
10 years
2

Atrial fibrillation burden

Atrial fibrillation burden - time proportion of AF episodes, number of episodes, longest episode duration (measured during 7-day ECG monitoring in the blanking period and annually thereafter)

Time frame
10 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.